Neural pathways visualization

We empower exceptional teams in psychedelic medicine and consciousness expansion

Our Thesis

Humanity faces a mounting mental health crisis that cannot be properly addressed within the framework of existing treatment options. This shortage of solutions applies more broadly to an unending number of conditions affected by the central nervous system. The resurgence of interest in psychedelic therapies, combined with recent breakthroughs in precision neuromedicine and machine learning, represents an imminent, new wave of transformative mind-body optimization tools. Mystic Ventures thus makes targeted investments in early-stage companies at the intersection of biotechnology, AI, and longevity, while ultimately aiming to elevate consciousness at scale.

Portfolio Focus

Pharmaceuticals

Novel compounds and therapeutic applications

Clinical Infrastructure

Platforms enabling therapeutic delivery

Digital Therapeutics

Technology-enabled therapeutic experiences

Building the Future of Mental Healthcare

If you're a founder working on innovative solutions in psychedelic medicine or consciousness expansion, we'd love to hear from you.

Get in Touch →